WHERE ARE YOU?

Concept Pre-Sub Submission prep Newly cleared Raising Exit Postmarket & security

THE TAPE

FDA opens a comment docket on the device regulatory science gaps of the next decade FDA makes the Boston Scientific Imager II removal a Class I recall Labs push the RESULTS Act after CMS cuts 775 test codes by the full 15 percent Boston Scientific clears SpaceOAR Flex, a rectal spacer the physician can stop mid-injection Shockwave founder Daniel Hawkins takes the board chair at Solenic Medical NeuroSigma takes its ADHD nerve stimulator into psychiatry clinics through Firefly's EEG network Intuitive wins a CE mark for adult cardiac surgery with da Vinci 5 Forj Medical opens a Costa Rica plant with ISO Class 8 cleanrooms and 50 staff Marani Health clears the M•care system for fetal and maternal monitoring at home FDA opens a comment docket on the device regulatory science gaps of the next decade FDA makes the Boston Scientific Imager II removal a Class I recall Labs push the RESULTS Act after CMS cuts 775 test codes by the full 15 percent Boston Scientific clears SpaceOAR Flex, a rectal spacer the physician can stop mid-injection Shockwave founder Daniel Hawkins takes the board chair at Solenic Medical NeuroSigma takes its ADHD nerve stimulator into psychiatry clinics through Firefly's EEG network Intuitive wins a CE mark for adult cardiac surgery with da Vinci 5 Forj Medical opens a Costa Rica plant with ISO Class 8 cleanrooms and 50 staff Marani Health clears the M•care system for fetal and maternal monitoring at home

Series B2

UltraSight raises $24M Series B2 with Mayo Clinic Ventures and NYU in the round

MedDevice Startups Staff · 6 days ago · 2 min read · Via MassDevice

UltraSight raised $24 million in a Series B2 led by the Alive HealthTech Grow Fund. Mayo Clinic Ventures, NYU, Iron Nation, Deep Insight, Star51 Capital, Connecticut Innovations and eHealth Ventures also took part.

UltraSight sells software that runs on ultrasound machines a clinic already owns. Its Ecosystem platform walks a nurse or medical assistant through a focused echocardiogram, then routes the images and analytics back to the cardiology team. More than 10 commercial sites had it in workflow as of September.

CEO Davidi Vortman said the cleared portfolio keeps widening to cover more cardiac imaging workflows. The round funds US commercial expansion and new software for intensive care and circulatory support settings. Two clearances in different care settings is what lets a guidance vendor sell one contract to a health system instead of one department.

Questions & Answers

How much did UltraSight raise in its Series B2?

UltraSight raised $24 million in a Series B2 announced in September 2026, led by the Alive HealthTech Grow Fund.

Who invested in UltraSight's $24M Series B2?

The Alive HealthTech Grow Fund led the round. Mayo Clinic Ventures, NYU, Iron Nation, Deep Insight, Star51 Capital, Connecticut Innovations and eHealth Ventures also took part.

What does UltraSight's Ecosystem platform do?

UltraSight's Ecosystem is AI software that guides clinical staff without sonography training through a focused echocardiogram on ultrasound equipment a site already owns, with a training curriculum and real-time analytics. More than 10 commercial sites were using it as of September 2026.

← Back to Fundraising